Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy.

Cruse B, Cysique LA, Markus R, Brew BJ.

J Neurovirol. 2012 Aug;18(4):264-76. doi: 10.1007/s13365-012-0092-3. Epub 2012 Apr 14. Review.

PMID:
22528476
2.

Cerebrovascular disease in highly active antiretroviral therapy-treated individuals: incidence and risk factors.

Monforte Ad, Bongiovanni M.

J Neurovirol. 2005;11 Suppl 3:34-7. Review.

PMID:
16540453
3.
4.

HIV infection and advanced age emerging epidemiological, clinical, and management issues.

Manfredi R.

Ageing Res Rev. 2004 Jan;3(1):31-54. Review.

PMID:
15164725
5.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
6.

Perspective on HIV infection and aging: emerging research on the horizon.

Casau NC.

Clin Infect Dis. 2005 Sep 15;41(6):855-63. Epub 2005 Jul 28. Review.

PMID:
16107986
7.

HIV infection and bone disease: implications for an aging population.

Cotter AG, Mallon PW.

Sex Health. 2011 Dec;8(4):493-501. doi: 10.1071/SH11014. Review.

PMID:
22127034
8.

Optimal antiretroviral therapy for aging.

Cordery DV, Cooper DA.

Sex Health. 2011 Dec;8(4):534-40. doi: 10.1071/SH11026. Review.

PMID:
22127040
9.

HIV-associated kidney disease in the context of an aging population.

Naftalin C, Nathan B, Hamzah L, Post FA.

Sex Health. 2011 Dec;8(4):485-92. doi: 10.1071/SH10146. Review.

PMID:
22127033
10.

Cryptococcal disease and HIV infection.

Waters L, Nelson M.

Expert Opin Pharmacother. 2005 Dec;6(15):2633-44. Review.

PMID:
16316302
11.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
12.

Human immunodeficiency virus (HIV) and stroke: targets for intervention.

Connor M.

Infect Disord Drug Targets. 2010 Apr;10(2):76-83. Review.

PMID:
20166974
13.

Cerebrovascular diseases in HIV-infected patients.

Monsuez JJ, Goujon C, Wyplosz B, Couzigou C, Escaut L, Vittecoq D.

Curr HIV Res. 2009 Sep;7(5):475-80. Review.

PMID:
19534663
14.

Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease.

Manzardo C, Zaccarelli M, Agüero F, Antinori A, Miró JM.

J Acquir Immune Defic Syndr. 2007 Sep;46 Suppl 1:S9-18. Review.

PMID:
17713424
15.

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

Ando M, Tsuchiya K, Nitta K.

Clin Exp Nephrol. 2012 Jun;16(3):363-72. doi: 10.1007/s10157-012-0585-7. Review.

PMID:
22294158
16.

The changing epidemiology of HIV-infected patients in the intensive care unit.

Akgün KM, Pisani M, Crothers K.

J Intensive Care Med. 2011 May-Jun;26(3):151-64. doi: 10.1177/0885066610387996. Epub 2011 Mar 24. Review.

PMID:
21436170
17.

HIV disease and advanced age: an increasing therapeutic challenge.

Manfredi R.

Drugs Aging. 2002;19(9):647-69. Review.

PMID:
12381235
18.

HIV-associated neurocognitive disorders (HAND).

Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Gill H, Attali M, Asher I.

Isr Med Assoc J. 2015 Jan;17(1):54-9. Review.

19.

Current trends of HIV disease of the mouth.

Frezzini C, Leao JC, Porter S.

J Oral Pathol Med. 2005 Oct;34(9):513-31. Review.

PMID:
16138890
20.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503

Supplemental Content

Support Center